Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Formula 1 and Sky Group set to co-produce Grand Prix broadcast for kids

    05/06/2023

    France bans short-haul flights where trains are available

    05/06/2023

    Study suggests flavanol-rich diet may reduce risk of memory loss

    02/06/2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram TikTok
    Tell Me The Good NewsTell Me The Good News
    Subscribe
    • Home
    • Climate
    • Entertainment
    • Health
    • Science
    • Tech
    • More
      • Arts
      • Business
      • Education
      • Family
      • Heroes
      • News
      • People
      • Politics
      • Sport
      • Travel
    Tell Me The Good NewsTell Me The Good News

    Latest News:

    • Formula 1 and Sky Group set to co-produce Grand Prix broadcast for kids
    • France bans short-haul flights where trains are available
    • Study suggests flavanol-rich diet may reduce risk of memory loss
    • 10 songs GUARANTEED to put you in a good MOOD
    • 10 REASONS to have faith in HUMANITY
    Home » Important moment in MS research as new trial begins
    Health

    Important moment in MS research as new trial begins

    By Matthew Sloan05/04/2023Updated:05/04/2023No Comments3 Mins Read
    Facebook Twitter LinkedIn Tumblr Email
    Important moment in MS research as new trial begins.
    Share
    Facebook Twitter LinkedIn Email

    A new trial has begun in the UK, researching the effect existing drugs can have on the development of MS.

    A new ‘Octopus’ trial has started in the UK this month with the aim of slowing down the progression of multiple sclerosis (MS).

    The MS Society – funders of the trial – estimate that the autoimmune condition affects around 130,000 people in the UK.

    The trial has been hailed as a “major moment in MS research”.

    Multiple sclerosis – what is MS?

    MS stands for multiple sclerosis.
    Credit: commons.wikimedia.org

    Multiple sclerosis is a neurodegenerative disease that affects the brain and spinal cord.

    It happens when the immune system mistakenly attacks the myelin sheath – a fatty layer that surrounds and protects the nerves. The sheath and potentially the nerves become damaged and scarred.

    Damage to the nerves adversely affects the messages they send to the brain, delaying these messages or preventing them completely. This can affect the MS sufferer’s speech, movement, and dexterity.

    No cure currently exists for MS, but treatments can ease symptoms and control the condition. This treatment varies depending on the patient’s specific difficulties and symptoms.

    The ‘Octopus’ trial – a critical moment in MS research

    The 'Octopus' trial is a critical moment for research.
    Credit: Unsplash/ Walter Otto

    The new trial has begun in the UK. It will explore the theory that existing drugs can be repurposed to help delay the progression of MS. Similar research has previously been used to test drugs for coronavirus and prostate cancer.

    The term ‘Octopus trial’ derives from the trial’s multi-arm, multi-stage nature. Its design means several drugs can be tested simultaneously, and more can be added or removed as results become clearer.

    The first trial drugs are the diabetes drug metformin and a high-dose alpha-lipoic acid. Germany has already approved the latter for treating neuropathy.

    Professor Jeremy Chataway of the National Hospital for Neurology and Neurosurgery in London spearheads the trial. Chataway described the trial as “a machine for testing drugs for progressive MS”.

    He added, “Octopus has the potential to change the clinical trials landscape around the world, and we won’t stop until we have the treatments that transform the lives of everyone with MS”.

    Bringing hope to MS sufferers – the trial begins this month

    The trial begins this month.
    Credit: Pexels/ EVG Kowalievska

    Stage one of the trial began this month, consisting of 375 patients. Stage two will increase the number of participants to 1,000.

    MS sufferer Alisa Guidi became one of the first to join the trial this month. She was diagnosed with MS in 1999.

    After a thorough neurological examination, including brain scans and blood tests, she recently received her first dose of the trial drugs.

    Guidi knows she may be in the placebo group and therefore receive no real treatment. However, she hopes the ‘Octopus’ trial will achieve its aim of finding ways to slow or stop MS progression.

    Share. Facebook Twitter LinkedIn Tumblr Email
    Matthew Sloan

      Matthew Sloan is the Assistant Editor and a writer for Tell Me The Good News. He has a BA in English and Spanish and an MA in Translation. A self-confessed city boy, Matthew feels most at home in the hustle and bustle of urban environments and loves nothing more than finding the best bars and restaurants along his travels. He has spent time living in Spain but currently resides in his hometown of Belfast.

      Related Posts

      Formula 1 and Sky Group set to co-produce Grand Prix broadcast for kids

      05/06/2023

      France bans short-haul flights where trains are available

      05/06/2023

      Study suggests flavanol-rich diet may reduce risk of memory loss

      02/06/2023

      Comments are closed.

      Demo
      Our Picks

      Literacy scheme helps 69 years old man read for first time

      19/04/2023

      Study suggests flavanol-rich diet may reduce risk of memory loss

      02/06/2023

      Top 10 most inspiring teenagers in the world

      16/08/2022

      Missing beagle returns home with winning ribbon from dog show

      15/08/2022
      Stay In Touch
      • Facebook 4.1K
      • Twitter 3K
      • Instagram 45.6K
      • TikTok
      Don't Miss

      Formula 1 and Sky Group set to co-produce Grand Prix broadcast for kids

      News 05/06/2023

      Formula 1 and Sky Group will collaborate in a joint effort to produce a Grand…

      France bans short-haul flights where trains are available

      05/06/2023

      Study suggests flavanol-rich diet may reduce risk of memory loss

      02/06/2023

      10 songs GUARANTEED to put you in a good MOOD

      01/06/2023

      Subscribe to Updates

      Get the latest creative news from SmartMag about art & design.

      The Good News Playlist

      • Home
      • About Us
      • Authors
      • Privacy Policy
      • Terms and conditions

      Follow Us

      A good news website dedicated to bringing you only the most uplifting stories worldwide.

      Facebook Twitter Instagram

      Contact Us

      Our Address:
      19 Arthur St, Belfast, Northern Ireland, BT1 4GA.

      We are open: Mon - Fri 08.00 - 18.00

      email [email protected]

      Subscribe to Updates

      Sign up to our newsletter so you get good news articles straight to your inbox every day!

      Type above and press Enter to search. Press Esc to cancel.